Literature DB >> 21638045

Insights into the permeability of drugs and drug-like molecules from MI-QSAR and HQSAR studies.

Ranajit N Shinde1, K Srikanth, M Elizabeth Sobhia.   

Abstract

Membrane-interaction QSAR (MI-QSAR) and Holographic QSAR (HQSAR) analyses have been performed on a diverse set of drugs and drug-like molecules. MI-QSAR combines a set of membrane-solute interaction properties calculated during molecular dynamics simulation with the set of classical solute descriptors to predict the biological behavior of drugs and drug-like molecules. HQSAR is a technique which employs fragment fingerprints or molecular holograms as predictive variables of biological activity. A data set of 60 structurally diverse molecules with permeability coefficients were used to construct significant MI-QSAR and HQSAR models of Caco-2 cell permeation. A statistically meaningful MI-QSAR model was obtained with r (2) = 0.805 and q (2) = 0.696. Subsequently, HQSAR models were developed on the same data set. The best HQSAR model (r (2) = 0.915, q (2) = 0.539) was obtained with fragment distinctions atom, bond, donor and acceptor with atom count 4 to 7. The predictions for training and test set molecules are in good agreement with experimental results and show the potential of models for untested compounds. This displays the importance of MI-QSAR and HQSAR analysis in estimating ADME properties characterized by the transport of solutes through biological membranes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21638045     DOI: 10.1007/s00894-011-1121-5

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  30 in total

1.  Link between drug absorption solubility and permeability measurements in Caco-2 cells.

Authors:  V Pade; S Stavchansky
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

Review 2.  ADMET in silico modelling: towards prediction paradise?

Authors:  Han van de Waterbeemd; Eric Gifford
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

3.  Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight.

Authors:  G Camenisch; J Alsenz; H van de Waterbeemd; G Folkers
Journal:  Eur J Pharm Sci       Date:  1998-10       Impact factor: 4.384

4.  Theoretical calculation and prediction of Caco-2 cell permeability using MolSurf parametrization and PLS statistics.

Authors:  U Norinder; T Osterberg; P Artursson
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

5.  In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.

Authors:  S Yee
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

Review 6.  Preferred conformation and molecular packing of phosphatidylethanolamine and phosphatidylcholine.

Authors:  H Hauser; I Pascher; R H Pearson; S Sundell
Journal:  Biochim Biophys Acta       Date:  1981-06-16

7.  Predicting blood-brain barrier partitioning of organic molecules using membrane-interaction QSAR analysis.

Authors:  Manisha Iyer; Rama Mishra; Yi Han; A J Hopfinger
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

8.  Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators.

Authors:  Kathia M Honorio; Richard C Garratt; Adriano D Andricopulo
Journal:  Bioorg Med Chem Lett       Date:  2005-06-15       Impact factor: 2.823

9.  Membrane-interaction QSAR analysis: application to the estimation of eye irritation by organic compounds.

Authors:  A S Kulkarni; A J Hopfinger
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

10.  The fluid mosaic model of the structure of cell membranes.

Authors:  S J Singer; G L Nicolson
Journal:  Science       Date:  1972-02-18       Impact factor: 47.728

View more
  1 in total

1.  Development of a Hierarchical Support Vector Regression-Based In Silico Model for Caco-2 Permeability.

Authors:  Giang Huong Ta; Cin-Syong Jhang; Ching-Feng Weng; Max K Leong
Journal:  Pharmaceutics       Date:  2021-01-28       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.